Events

Rappel de BioSensors_BioMatrix NeoFlex Drug Eluting Coronary Stent System

Selon New Zealand Medicines and Medical Devices Safety Authority, ce/cet/cette rappel concerne un dispositif en/au/aux/à New Zealand qui a été fabriqué par Biosensors Europe SA.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    19857
  • Date de mise en oeuvre de l'événement
    2016-03-07
  • Pays de l'événement
    New Zealand
  • Source de l'événement
    NZMMDSA
  • URL de la source de l'événement
    https://medsafe.govt.nz/hot/Recalls/RecallSearch.asp
  • Notes / Alertes
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Notes supplémentaires dans les données
    Recalling Organisation: InterMed Medical Ltd, 71 Apollo Drive, Albany, AUCKLAND 1311
  • Cause
    Manufacturer discovered during routine lot release testing that several production lots did not meet the balloon rated burst performance specifications. after full investigation, manufacturer concluded that the compromised balloon performance was caused by certain characteristics in the manufacturing process. biosensors positively identified production lots manufactured between october to december 2015 that could have been similarly affected., the compromised balloon performance may potentially lead to delay in inflation or deflation of the balloon; or balloon burst when the balloon is inflated above the nominal pressure. this could result in procedural complications and lead to serious deterioration in the patient's state of health during pci., patients who have already been implanted with an affected device are not impacted by this field safety corrective action. no field complaint or patient injury has been reported associated with the compromised balloon performance.
  • Action
    Product to be returned to supplier

Device

BioSensors_BioMatrix NeoFlex Drug Eluting Coronary Stent System
  • Modèle / numéro de série
    Model: BMXP-3511, BMXP-3518, BMXP-4018, BMXP-4024, Affected: Batches: W15100548 W15100236 W15100237 W15100238 W15110086 W15120234
  • Manufacturer
    Biosensors Europe SA

Manufacturer

Biosensors Europe SA